The concept of psoriasis as a systemic inflammation: implications for disease management von Reich, K.

Volltext

A new treatment option for paediatric psoriasis von Reich, K.

Volltext

Mental health concerns during the COVID-19 pandemic as revealed by helpline calls von Brülhart, Marius, Klotzbücher, Valentin, Lalive, Rafael, Reich, Stephanie K.

Volltext

Definition of treatment goals for moderate to severe psoriasis: a European consensus von Mrowietz, U, Kragballe, K, Reich, K, Spuls, P, Griffiths, C. E. M, Nast, A, Franke, J, Antoniou, C, Arenberger, P, Balieva, F, Bylaite, M, Correia, O, Daudén, E, Gisondi, P, Iversen, L, Kemény, L, Lahfa, M, Nijsten, T, Rantanen, T, Reich, A, Rosenbach, T, Segaert, S, Smith, C, Talme, T, Volc-Platzer, B, Yawalkar, N

Volltext

Approach to managing patients with nail psoriasis von Reich, K

Volltext

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-mar... von Deodhar, A, Mease, P J, McInnes, I B, Baraliakos, X, Reich, K, Blauvelt, A, Leonardi, C, Porter, B, Das Gupta, A, Widmer, A, Pricop, L, Fox, T

Volltext

The value of subcutaneous vs. oral methotrexate: real‐world data from the German psoriasis registry PsoBest von Reich, K., Sorbe, C., Griese, L., Reich, J.L.K., Augustin, M.

Volltext

Conductivity of quantum dot arrays von Reich, K V

Volltext

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial von Papp, K., Thaçi, D., Reich, K., Riedl, E., Langley, R.G., Krueger, J.G., Gottlieb, A.B., Nakagawa, H., Bowman, E.P., Mehta, A., Li, Q., Zhou, Y., Shames, R.

Volltext

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC von Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.

Volltext

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) von Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

Volltext

Metal–insulator transition in films of doped semiconductor nanocrystals von Chen, Ting, Reich, K. V., Kramer, Nicolaas J., Fu, Han, Kortshagen, Uwe R., Shklovskii, B. I.

Volltext

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis von Papp, K.A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R.G., Cather, J., Gottlieb, A.B., Thaçi, D., Krueger, J.G., Russell, C.B., Milmont, C.E., Li, J., Klekotka, P.A., Kricorian, G., Nirula, A.

Volltext

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial von Reich, K., Sullivan, J., Arenberger, P., Mrowietz, U., Jazayeri, S., Augustin, M., Parneix, A., Regnault, P., You, R., Milutinovic, M.

Volltext

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is m... von Bruin‐Weller, M., Thaçi, D., Smith, C.H., Reich, K., Cork, M.J., Radin, A., Zhang, Q., Akinlade, B., Gadkari, A., Eckert, L., Hultsch, T., Chen, Z., Pirozzi, G., Graham, N.M.H., Shumel, B.

Volltext

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials von Simpson, E.L., Lacour, J.‐P., Spelman, L., Galimberti, R., Eichenfield, L.F., Bissonnette, R., King, B.A., Thyssen, J.P., Silverberg, J.I., Bieber, T., Kabashima, K., Tsunemi, Y., Costanzo, A., Guttman‐Yassky, E., Beck, L.A., Janes, J.M., DeLozier, A.M., Gamalo, M., Brinker, D.R., Cardillo, T., Nunes, F.P., Paller, A.S., Wollenberg, A., Reich, K.

Volltext

Comparison of ixekizumab with ustekinumab in moderate‐to‐severe psoriasis: 24‐week results from IXORA‐S, a phase III study von Reich, K., Pinter, A., Lacour, J.P., Ferrandiz, C., Micali, G., French, L.E., Lomaga, M., Dutronc, Y., Henneges, C., Wilhelm, S., Hartz, S., Paul, C.

Volltext

The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti‐TNF use: a time‐trend study von Reich, K. M., Chang, H.‐J., Rezaie, A., Wang, H., Goodman, K. J., Kaplan, G. G., Svenson, L. W., Lees, G., Fedorak, R. N., Kroeker, K. I.

Volltext

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations von Nast, A., Smith, C., Spuls, P.I., Avila Valle, G., Bata‐Csörgö, Z., Boonen, H., De Jong, E., Garcia‐Doval, I., Gisondi, P., Kaur‐Knudsen, D., Mahil, S., Mälkönen, T., Maul, J.T., Mburu, S., Mrowietz, U., Reich, K., Remenyik, E., Rønholt, K.M., Sator, P.G., Schmitt‐Egenolf, M., Sikora, M., Strömer, K., Sundnes, O., Trigos, D., Van Der Kraaij, G., Yawalkar, N., Dressler, C.

Volltext

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest von Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., Augustin, M.

Volltext